We are thrilled to share the incredible success of our 2023 Future Without MS Gala . With unwavering dedication and support from our donor community, this event shattered all previous records, raising 4.4 million dollars . The outpouring of generosity from individuals and organizations alike is...
Last week, our scientist attended #MSMilan2023. The event was jointly hosted by #Ectrims & #Actrims and gathered MS experts from across the globe to meet and discuss some of the groundbreaking MS news and research. Our team shared and present 5 different topics: PAK1 and E2F1 dysregulation...
Congratulations to Tisch MSRCNY's 2023 Junior Investigator of the Year, Anjali Kumar, for her outstanding performance as the Best Junior Scientist! Anjali is the clinical research assistant, working with the clinical team and Dr. Sadiq on the Phase 2 stem cell trial. She plays a role in assessing...
Last week, our researchers and physicians discussed a paper regarding the association of higher Ocrelizumab exposure with reduced disability progression in MS. Ocrelizumab, or Ocrevus, is a prescription drug commonly used to treat both progressive and relapsing-remitting MS. Ocrelizumab was shown...
Last week our researchers and physicians discussed a paper about bile acid metabolites, and their implications in MS research. Bile acid metabolites are signaling molecules that work throughout the central nervous system, and researchers identified lower levels of these metabolites in MS patients...
Dr. Nicolas Daviaud was recently interviewed by the team at Interesting Engineering. We are excited to share the piece, which highlights Dr. Daviaud's work with cerebral organoids! Click here to read the full article online. Click here to read the full PDF version.
Advancing multiple sclerosis with cerebral organoids: an interview with Nicolas Daviaud With this year marking ten years since the development of cerebral organoids, we spoke to Nicolas Daviaud to learn how the Tisch Multiple Sclerosis Research Center of New York (USA) is using them as a model for...
We’re excited to share that our Center was featured in an article in The New Yorker! Drawing from interviews with some of our patients, our Principal Investigators, and Dr. Sadiq, the piece highlights how our comprehensive approach to MS research has led to some of the most significant recent...